newsfilter
← Latest News
Business Wire·

Edwards Lifesciences Reports Second Quarter Results

EW

Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended June 30, 2026. Highlights Q2 sales grew 13.6% to $1.74 billion1, constant currency2 sales grew 12.5% Q2 TAVR sales grew